ESPR EBITDA Margin
Esperion Therapeutics Inc · EBITDA Margin
ESPR EBITDA Margin
Latest reported-56.14%period ending
ESPR Quarterly EBITDA Margin (-562792.00% → -56.14%)
Quarterly ebitda margin
High-resolution chart · PNG
ESPR ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -56.1358% | |
| 51.2532% | |
| -10.6014% | |
| 9.4532% | |
| -32.3071% | |
| -7.045% | |
| -27.9207% | |
| -65.2707% | |
| 54.8031% | |
| -128.0031% | |
| -77.2145% | |
| -137.0783% | |
| -194.2168% | |
| -218.2272% | |
| -215.274% | |
| -275.5055% | |
| -225.7167% | |
| -334.6276% | |
| -385.7242% | |
| -79.6158% | |
| -1,036.0617% | |
| -989.6763% | |
| -2,096.1649% | |
| 60.9553% | |
| -4,020.2174% | |
| -5,877.9022% | |
| -6,553.4149% | |
| -5,515.8859% | |
| 59.8271% | |
| -32.5059% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -766,500% | |
| -802,000% | |
| -504,000% | |
| -775,600% | |
| -756,000% | |
| -562,792% |